| __timestamp | BioMarin Pharmaceutical Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 1499100000 |
| Thursday, January 1, 2015 | 402271000 | 1923500000 |
| Friday, January 1, 2016 | 476593000 | 2351400000 |
| Sunday, January 1, 2017 | 554336000 | 2564000000 |
| Monday, January 1, 2018 | 604353000 | 2397300000 |
| Tuesday, January 1, 2019 | 680924000 | 2503400000 |
| Wednesday, January 1, 2020 | 737669000 | 3344600000 |
| Friday, January 1, 2021 | 759375000 | 4529200000 |
| Saturday, January 1, 2022 | 854009000 | 4179100000 |
| Sunday, January 1, 2023 | 937300000 | 4650100000 |
| Monday, January 1, 2024 | 1009025000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Viatris Inc. and BioMarin Pharmaceutical Inc. have showcased contrasting trends in their SG&A expenditures. From 2014 to 2023, Viatris Inc. consistently reported higher SG&A expenses, peaking at approximately $4.65 billion in 2023, a staggering 210% increase from 2014. In contrast, BioMarin's SG&A expenses grew by about 210% over the same period, reaching around $937 million in 2023. This divergence highlights Viatris's expansive operational scale compared to BioMarin's more focused approach. Such insights are invaluable for investors and stakeholders aiming to gauge operational efficiency and strategic priorities. As the industry evolves, monitoring these trends will be key to understanding each company's market positioning and financial health.
Comparing SG&A Expenses: Viatris Inc. vs Summit Therapeutics Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Viatris Inc. and Insmed Incorporated
Who Optimizes SG&A Costs Better? Viatris Inc. or Madrigal Pharmaceuticals, Inc.
Viatris Inc. vs Exelixis, Inc.: SG&A Expense Trends
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Viatris Inc. and Geron Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Viatris Inc. and Evotec SE
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Novavax, Inc. Trends and Insights